how long before PubMed Scrubs

All Studies Ivermectin?

"Ivermectin, a potential anticancer drug derived from an anti-parasitic drug"

Pharmacol Res. 2021 Jan; 163: 105207.

Published online 2020 Sep 21. doi: 10.1016/j.phrs.2020.105207

Graphical abstract

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase. On the other hand, ivermectin promotes programmed cancer cell death, including apoptosis, autophagy and proptosis. Ivermectin induces apoptosis and autophagy is mutually regulated. Interestingly, ivermectin can also inhibit tumor stem cells and reverse multidrug resistance and exerts the optimal effect when used in combination with other chemotherapy drugs.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/

"Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations"